mIHC using TSA amplification is not recommended for frozen tissue sections because microwave treatments will destroy tissue morphology. a HER2+ breast cancer, illustrating some points. Spatial transcriptomic analysis of a luminal B breast tumor demonstrated that important additional insight can be gained from this new technique. Finally, the development of a multiplex panel to identify proliferating B cells, Tfh,and Tfrcells on the same tissue section demonstrates their co-localization in tertiary lymphoid structures. Keywords:tumor immune microenvironment, breast cancer, tumor-infiltrating lymphocytes, tertiary lymphoid structure, fluorescent multiplex immunohistochemistry == Introduction == The tumor immune microenvironment (TIME) plays a critical role in Tankyrase-IN-2 cancer development, progression, and treatment responses. It is defined by the immune cells, antigens, and soluble factors (including cytokines, chemokines, and immunoglobulins) that surround and influence tumor cells. The molecular and cellular composition of the TIME influences disease outcome via the balance between pro- and anti-tumor innate and adaptive immune responses. Human tumor-infiltrating lymphocytes (TILs) such as CD8+cytotoxic T cells, conventional CD4+T cells, T follicular helper cells (TFH) Tankyrase-IN-2 (van der Leun et al., 2020), B cells (Wouters and Nelson, 2018), and natural killer cells (Stabile et al., 2017) are generally associated with favorable (anti-tumor) immune responses, together with T cells (Lo Presti et al., 2020) and eosinophils (Grisaru-Tal et al., 2020). Many studies also show that tumor-associated macrophages and neutrophils, myeloid-derived suppressor cells, and regulatory T (Treg) cells are key drivers of cancer progression via their ability to promote tumor cell functions such as proliferation, aggressiveness, and dissemination in parallel with suppression of T cell-mediated anti-tumor immunity (Lecot et al., 2019;Ohue and Nishikawa, 2019;Davidov et al., 2020). A caveat is that immune cells are functionally heterogeneous and plastic with most capable of divergent behavior based on their activation status and the surrounding microenvironment. Beyond the TIME Tankyrase-IN-2 composition, studying the location and spatial distribution of immune cells can provide a framework for understanding tumor biology and identifying potential predictive biomarkers. Spatial characteristics of tumors can be initially stratified based on tissue architecture such as intratumoral, peritumoral (or stromal) areas, and the invasive margin. In human breast cancer (BC), both intratumoral and stromal TIL have been consistently and significantly associated with overall survival (OS) in the HER2+and triple-negative subgroups (Dieci et al., 2015;Hendry et al., 2017). Recent studies of TIL subsets in BC revealed stromal CD3+T cells and FOXP3+Treg were associated with disease-free survival (DFS) but not their intratumoral counterpart while both intratumoral and stromal CD8+cytotoxic T cells predict longer DFS (Koletsa et al., 2020). Recent studies of tumor and immune spatial distribution at the single-cell level demonstrated a significant correlation with disease outcomes. For example, T cells and proliferating tumor cells were found in close proximity in immunoedited colorectal cancer metastases whereas short distances were seen between T cells and PD-L1+cells in non-immunoedited metastases (Angelova et al., 2018). Analysis of matched primary and recurrent head and neck squamous cell carcinoma detected CD8+T cell exclusion from tumor nests and close proximity between Treg or myeloid cells with tumor cells at relapse (Banik et al., 2020). TIL in the invasive margin or stroma can form tertiary lymphoid structure (TLS), which are similar to secondary lymphoid organs with a T cell zone adjacent to a B cell follicle that contains germinal center B cells, TFHcells (Garaud et al., 2019), and mature dendritic cells (Dieu-Nosjean et al., 2008). A TLS presence is associated with favorable clinical outcomes (Dieu-Nosjean et al., 2008;Silina et al., 2018) and responses to immune checkpoint blockade (Cabrita et al., 2020;Helmink et al., 2020;Petitprez et al., 2020). The TLS maturation stage also harbors important prognostic information on the risk of disease recurrence Tankyrase-IN-2 (Posch et al., 2018;Silina et al., 2018). This means that deeper compositional and spatial analysis of immune cells infiltrating the tumor is needed to achieve a better understanding of effective anti-tumor immunity and discover new potential biomarkers. Recent technological advances for phenotypic and transcriptional analysis of individual cells in the context of their spatial distribution are new, powerful tools for studying the TIME and identifying potential biomarkers. Fluorescent multiplex immunohistochemistry (mIHC) can simultaneously Mouse monoclonal to HK1 evaluate multiple biological markers on a single formalin-fixed, paraffin-embedded (FFPE) section. The objective of this review is to comparatively evaluate mIHC relative to more established TIME analytical techniques. We will consider.